Darktrace—Shareholders rejected Mike Lynch's representative from board over fraud trial concerns
At Darktrace's 2023 annual meeting, 56.67% of shareholders voted against the election of Patrick Jacob as a non-executive director representing Mike Lynch's interests. Institutional investors cited Lynch's US fraud trial as creating 'unhelpful headline risk' for Darktrace. Lynch later lost his right to a board seat entirely when his stake fell below 10%.
Scoring Impact
| Topic | Direction | Relevance | Contribution |
|---|---|---|---|
| Corporate Governance | +toward | primary | +1.00 |
| Overall incident score = | +0.059 | ||
Score = avg(topic contributions) × significance (medium ×1) × confidence (0.59)× agency (incidental ×0.1)
Evidence (1 signal)
Shareholders rejected Mike Lynch's representative from board over fraud trial concerns
At Darktrace's 2023 annual meeting, 56.67% of shareholders voted against the election of Patrick Jacob as a non-executive director representing Mike Lynch's interests. Institutional investors cited Lynch's US fraud trial as creating 'unhelpful headline risk' for Darktrace. Lynch later lost his right to a board seat entirely when his stake fell below 10%.